DIARY-China corporate earnings week ahead

Imeik Technology Development Confirms Chairwoman Has Not Reduced Shareholding Since IPO

Imeik Technology: Distributor's Botulinum Toxin Product Recently Secures Drug Registration Certificate, Company Crafting Sales Strategy

Imeik Technology: Company Meets Diverse User Needs with Comprehensive and Differentiated Product Portfolio

Imeik's Botulinum Toxin Product Approved Amid Fierce Market Competition

Imeik Technology Development Gets Approval for Botox Injection; Shares Up 3%

"Medical Beauty Giant" Stumbles: Can Jian Jun Revive Imeik's Billion-Dollar Legend?

Imeik Tech Shifts from Leader to Laggard: Four Consecutive Quarters of Declining Performance, 1344% Premium Acquisition of "Youth Needle" Giant Entangles in $1.6B Agency Arbitration

From 19-Year Legal Career to Board Secretary of Imeik with 50 Billion Market Cap

Imeik Technology Development Says Board Elected Jian Jun as Chairwoman

BRIEF-Imeik Technology Development's Board Elects Chairwoman

Imeik Technology Development Co.,Ltd.: Product Sales and Operational Data Subject to Periodic Reports

From High Profitability to Growth Momentum: Imeik (300896.SZ) Builds a New Pattern of Diversified Development

Imeik Technology Faces Growth Slowdown: Q3 Revenue Drops 21% YoY to 570M Yuan, Adjusted Net Profit Falls 42% to 260M Yuan

BRIEF-Imeik Technology Development Q3 Net Profit Down 34.6% Y/Y

Imeik's Bold Move into Cosmetics Ingredients: What Does It Mean?

Controlling Shareholder Penalized for Insider Trading: Will "Hurun Rich List" Figure Be Cut Off by Hyaluronic Acid Giant?